Express Pharma

Vertex Pharma poised to dominate global gene therapy market with first CRISPR approval: GlobalData

The global cell and gene therapy market is expected to reach $80 billion in 2029, with a high CAGR of 51.6 per cent between 2023 and 2029, according to GlobalData